ESR1 and cancer: Furthermore, 3 CpGs located in genes not previously associated with cancer, PRAC2, TDRD10 and TMEM132C, were able to predict breast cancer overall survival, and more particularly survival of ER-positive patients (Table 1, Fig. 4), suggesting their potential as diagnostic and prognostic markers in BC.